Bull
$1.94
Szenariopreis
$1.860
-0.010 (-0.53%)Zum Schluss
Aemetis, Inc. is a renewable natural gas and renewable fuels company. The Company focused on the operation, acquisition, development and commercialization of technologies that lower fuel costs and reduce emissions. The Company’s segments include California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The California Ethanol segment consists of an approximately 65 million gallons per year ethanol plant in Keyes, California. The California Dairy Renewable Natural Gas segment is engaged in the production and sale of renewable natural gas and associated environmental attributes, consisting of anaerobic digesters located at diaries, a 36-mile biogas collection pipeline, and a biogas upgrading hub and pipeline interconnect that produces Renewable Natural Gas from the biogas. The India Biodiesel segment includes a biodiesel production plant in Kakinada, India with a production capacity of over 80 million gallons per year and administrative offices in Hyderabad, India.
Aemetis Inc (AMTX) is currently trading at $1.86, which is near its 5-day SMA of $1.88, showing some short-term stability. However, the stock has a high forward P/E ratio of 58.82, suggesting that investors expect substantial growth in the future, which may not materialize given the company's recent performance. The gross margin has improved significantly to 21.56% in Q2 2026, up from negative margins in previous quarters, indicating potential for profitability. However, the company also reported a net income loss of $9.37 million in Q2 2026, which poses a risk to its financial health. Therefore, while there are signs of recovery, the high valuation and ongoing losses suggest that it may be prudent to hold rather than buy at this time.
Ascendiant
$20
2025-06-06
Ascendiant
2025-06-06
Kursziel
$20
UBS
—
2025-05-09
UBS
2025-05-09
Kursziel
—
Ascendiant Capital
$19
2025-03-17
Ascendiant Capital
2025-03-17
Kursziel
$19
HC Wainwright & Co.
$28
2025-03-14
HC Wainwright & Co.
2025-03-14
Kursziel
$28
HC Wainwright & Co.
$28
2024-12-23
HC Wainwright & Co.
2024-12-23
Kursziel
$28
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

Aemetis Converts California Dairy Waste Methane into Renewable Natural Gas

Aemetis to Host Q2 2026 Earnings Call on August 6

Sky Quarry Signs Multi-Party MOU for Clean Fuel Innovation

Aemetis Set to Announce Q1 Earnings on May 7

Aemetis to Host Q1 2026 Earnings Call
Aemetis, Inc. is a renewable natural gas and renewable fuels company. The Company focused on the operation, acquisition, development and commercialization of technologies that lower fuel costs and reduce emissions. The Company’s segments include California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The California Ethanol segment consists of an approximately 65 million gallons per year ethanol plant in Keyes, California. The California Dairy Renewable Natural Gas segment is engaged in the production and sale of renewable natural gas and associated environmental attributes, consisting of anaerobic digesters located at diaries, a 36-mile biogas collection pipeline, and a biogas upgrading hub and pipeline interconnect that produces Renewable Natural Gas from the biogas. The India Biodiesel segment includes a biodiesel production plant in Kakinada, India with a production capacity of over 80 million gallons per year and administrative offices in Hyderabad, India. It operates in the Energy sector (INDUSTRIAL ORGANIC CHEMICALS industry).
Aemetis Inc (AMTX) is currently trading at $1.86, which is near its 5-day SMA of $1.88, showing some short-term stability. However, the stock has a high forward P/E ratio of 58.82, suggesting that investors expect substantial growth in the future, which may not materialize given the company's recent performance. The gross margin has improved significantly to 21.56% in Q2 2026, up from negative margins in previous quarters, indicating potential for profitability. However, the company also reported a net income loss of $9.37 million in Q2 2026, which poses a risk to its financial health. Therefore, while there are signs of recovery, the high valuation and ongoing losses suggest that it may be prudent to hold rather than buy at this time.
1 analysts cover AMTX: 0 rate it Buy, 1 Hold and 0 Sell. The average price target is 20.00.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.